ORKA
ORKA
NASDAQ · Biotechnology

Oruka Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$64.59
+0.52 (+0.81%)
As of May 9, 1:33 AM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 19 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -68.0% upside
Low Target $16.39
Average Target $20.70
High Target $27.30
Current Price $64.59
Current
$64.59
Target
$20.70
$16.39 $20.70 avg $27.30
Scenario Analysis
Bear Case
$16.39
-74.6%
Low target
Base Case
$20.70
-68.0%
Avg target
Bull Case
$27.30
+-57.7%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$91.00
-29.0% from high
52-Week Low
$8.91
+624.9% from low
Target vs 52W High
$20.70
-77.3% vs high
Next Earnings Report
May 20, 2026
9d
until earnings
EPS Est: $-0.56
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%